1. Signaling Pathways
  2. Epigenetics
  3. YTHDF
  4. YTHDC1 Isoform

YTHDC1

YTHDC1 is a nuclear m⁶A RNA reader that selectively binds m⁶A-containing RNA through its YTH domain and preferentially recognizes GG(m⁶A)C sequences[1]. Mechanistically, YTHDC1 controls nuclear RNA metabolism by promoting mRNA splicing and by mediating export of methylated mRNAs from the nucleus to the cytoplasm through SRSF3 and NXF1[2][3]. In AML models, YTHDC1 supports leukemia cell proliferation, survival, AML development, and leukemia stem cell self-renewal through an MCM4 DNA-replication mechanism[4]. Compared with related isoforms, YTHDC1 functions as the only nuclear YTH-family m⁶A-binding protein in this export pathway, whereas YTHDF2 mainly mediates cytoplasmic decay of methylated mRNAs and YTHDC2 has RNA helicase activity essential for mammalian germline meiosis[2][5]. For experimental applications, early YTHDC1 inhibitors that occupy the RNA-binding pocket disrupt YTHDC1-m⁶A RNA interaction, dissolve YTHDC1 condensates, and suppress oncogenic gene expression in AML cell lines[6].

YTHDC1 Related Products (1):

Cat. No. Product Name Effect Purity
  • HY-168610
    YTH-IN-1
    Inhibitor 98.66%
    YTH-IN-1 (compound N-7) is a pan-YTH domain inhibitor with the IC50 values of 39 μM, 34 μM, 35 μM, 48 μM and 30 μM for human YTHYTHDF1, YTHYTHDF2, YTHYTHDF3, YTHYTHDC1, and YTHYTHDC2, respectively.